Info@ThinkPinkRocks.com

HCT not precluded by prior second-generation TKI therapy in chronic, advanced phase CML

Allogeneic haematopoietic stem cell transplantation can be considered for chronic- and accelerated-phase chronic myeloid leukaemia patients with prior exposure to second-generation tyrosine kinase inhibitors, say Polish researchers.

Excerpt from:
HCT not precluded by prior second-generation TKI therapy in chronic, advanced phase CML

Share

Leave a Reply